GO:0010954 positive regulation of protein processing: Proteolytic Activation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0010954 describes any process that increases the rate, frequency or extent of protein maturation by peptide bond cleavage, a post-translational control point that converts inactive precursors into bioactive proteins.
• The term is a biological_process child of protein processing regulation and is mechanistically distinct from transcription, translation and non-proteolytic post-translational modifications.
• Key molecular players include inflammasome sensors such as NLRP3, the protease caspase-1, and regulatory kinases that phosphorylate or ubiquitinate processing enzymes.
• Dysregulated protein processing is implicated in cancer immune evasion, sepsis-associated pyroptosis, allergic airway inflammation and metabolic disease.
• CRISPR knockout, point-mutation, knock-in and overexpression models allow causal dissection of each step in the processing cascade.
• Combining CRISPR screening with proteomics, secretomics and activity-based probes is the current gold standard for mapping positive regulators of protein processing.
Description
GO:0010954, positive regulation of protein processing, is a Gene Ontology biological_process term defined as any process that increases the rate, frequency or extent of protein maturation by peptide bond cleavage. In practical terms, it covers the upstream signals, scaffolds and enzymes that accelerate the conversion of a pro-protein into its mature, functional form. This distinguishes it from the constitutive processing event itself and places it among the most dynamic and therapeutically tractable nodes of post-translational control. Researchers care about GO:0010954 because proteolytic maturation governs the output of major signalling pathways, including inflammasome-dependent cytokine release and immune checkpoint protein display. For example, NLRP3 inflammasome activation requires sequential proteolytic events that are themselves positively regulated by kinases, ubiquitin ligases and lipid-derived second messengers. Similarly, PD-L1 expression and function in the tumour microenvironment are shaped by post-translational processing steps that influence immune evasion. Because these events are fast, reversible and dose-sensitive, they are ideal targets for CRISPR-based functional genomics. Understanding which genes positively regulate protein processing therefore provides a direct route to identifying drug targets and biomarkers in inflammation, cancer and metabolic disease.
positive regulation of protein processing At A Glance
| GO ID | GO:0010954 |
|---|---|
| GO term | positive regulation of protein processing |
| Ontology | biological_process |
| Synonym | positive regulation of protein maturation by peptide bond cleavage |
| Major function | Increases the rate, frequency or extent of protein maturation by peptide bond cleavage |
| Parent process | regulation of protein processing |
| Opposite term | negative regulation of protein processing |
| Related process | protein maturation by peptide bond cleavage |
| Typical readout | Accumulation of mature cleaved protein product |
What Is GO:0010954?
In our own words, GO:0010954 refers to any cellular activity that enhances the maturation of a protein through cleavage of peptide bonds. It does not describe the cleavage reaction itself, but rather the regulatory inputs that make that cleavage faster, more frequent or more extensive. These inputs can include activating phosphorylation of a protease, ubiquitin-dependent assembly of a processing platform, or lipid signals that recruit processing components to the correct membrane. The synonym positive regulation of protein maturation by peptide bond cleavage captures the same idea. Because the term is a biological_process, it is best studied by measuring the mature product of a substrate rather than by measuring transcription or translation alone.
Why Is positive regulation of protein processing Important in Cell Biology?
GO:0010954 matters because proteolytic maturation is a decisive, irreversible step in many signalling pathways, and its positive regulators determine whether a cell mounts an inflammatory response, presents an immune checkpoint ligand, or commits to a differentiation programme. Unlike transcriptional control, positive regulation of protein processing can act within minutes and is often the point at which a pathway becomes pathologically amplified. This makes it a high-value area for target discovery in sepsis, cancer, allergy and metabolic disorders.
• Controls the speed and amplitude of inflammasome-dependent cytokine release.
• Shapes PD-L1 protein levels and tumour immune evasion.
• Is required for NLRP3 post-translational regulation during sepsis-associated macrophage pyroptosis.
• Links lipid signalling, such as lysophosphatidylcholine, to proteolytic activation platforms.
• Influences allergic airway inflammation through metabolite-driven protein modification.
• Provides a mechanistic explanation for rapid, transcription-independent cellular decisions.
• Offers druggable nodes because proteases and their activators are enzyme families with established inhibitor chemistry.
• Enables CRISPR functional genomics to separate processing regulators from transcription regulators.
• Connects to cancer metabolism through O-GlcNAcylation and ubiquitin-dependent homeostasis.
• Is a recurring theme in biomarker discovery for inflammatory and malignant disease.
What Happens During positive regulation of protein processing?
Signal recognition and platform assembly
In simple terms: The cell first senses a danger signal and builds a molecular platform where processing will happen.
Positive regulation of protein processing typically begins when a sensor or receptor detects a stimulus and nucleates a multi-protein platform. In the NLRP3 inflammasome, this step involves post-translational regulation of NLRP3 itself, including phosphorylation and ubiquitination events that license assembly. GITR has been shown to exacerbate lysophosphatidylcholine-induced macrophage pyroptosis through post-translational regulation of NLRP3, illustrating how a surface receptor can positively regulate a processing platform. The platform is not a passive scaffold; its composition determines whether processing proceeds rapidly or is held in check.
Activation of the processing protease
In simple terms: The protease that does the cutting must itself be switched on.
Once the platform is assembled, the executing protease undergoes activating conformational changes or cleavage. In inflammasome biology, caspase-1 activation is the canonical example, and its positive regulation is mediated by adaptor oligomerization and by kinases that modify the sensor. Because the protease is often synthesized as an inactive zymogen, positive regulation of protein processing frequently overlaps with the concept of zymogen activation. This step is a major point of pharmacological intervention and is commonly measured with activity-based probes.
Substrate recruitment and peptide bond cleavage
In simple terms: The active protease finds its target protein and cuts it at a specific site.
Substrate recruitment determines specificity. Positive regulators can increase processing by bringing substrate and protease into the same membrane microdomain, by removing inhibitory post-translational marks, or by changing substrate conformation. In the tumour microenvironment, processing of immune checkpoint proteins such as PD-L1 is influenced by the local cytokine and metabolic milieu, which in turn affects immune evasion. The cleavage event releases a mature product whose accumulation is the definitive readout of GO:0010954 activity.
Amplification and feedback control
In simple terms: Once cutting starts, the cell can amplify the response or shut it down.
Positive regulation of protein processing is often embedded in feed-forward loops. For example, a first cleavage product can recruit more platform components, accelerating further processing. Counter-regulatory mechanisms, including ubiquitin-dependent degradation of processing components, prevent runaway activation; FBXO31-mediated ubiquitination of OGT maintains O-GlcNAcylation homeostasis and restrains endometrial malignancy, showing how ubiquitin systems intersect with processing-related homeostasis. Histone lactylation and protein succinylation are additional layers that can tune the expression or activity of processing machinery.
Resolution and product fate
In simple terms: After cutting, the mature protein goes to work and the system resets.
The final phase determines the biological consequence. Mature cytokines are secreted, mature receptors are displayed, and mature enzymes enter their functional compartments. Positive regulation of protein processing therefore has a temporal signature: it is fast, self-limiting and tightly coupled to product removal. Experimental systems that measure both the mature product and the disappearance of the precursor are required to assign a gene to GO:0010954 confidently.
Key Genes Involved in GO:0010954 positive regulation of protein processing
The following genes and proteins are experimentally linked to positive regulation of protein processing or to the processing platforms it controls.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NLRP3 | Inflammasome sensor whose post-translational regulation licenses processing | Central to sepsis and inflammatory disease models |
| CASP1 | Cysteine protease that executes inflammatory cytokine maturation | Canonical readout of protein processing activation |
| GITR | Surface receptor that promotes NLRP3 post-translational regulation | Links co-stimulation to macrophage pyroptosis |
| CD274 (PD-L1) | Immune checkpoint ligand whose processing affects tumour evasion | Cancer immunotherapy target |
| OGT | O-GlcNAc transferase regulated by ubiquitination | Connects processing homeostasis to endometrial malignancy |
| FBXO31 | E3 ubiquitin ligase controlling OGT stability | Tumour suppressor context |
| BIK1 | Kinase that phosphorylates RbohD in plant immunity | Model for phosphorylation-dependent activation of processing-like outputs |
| RbohD | NADPH oxidase regulated by BIK1 phosphorylation | Plant immunity signalling node |
| FEN1 | DNA processing enzyme regulated by lysine acetylation | Methodological model for acetylation-dependent enzyme regulation |
| H4 histones | Lactylation sites H4K79 and H4K91 | Epigenetic layer influencing processing gene expression |
| Succinate-modified proteins | Succinylation targets in allergic airway inflammation | Metabolite-driven regulation of processing pathways |
| Caspase adaptors | Scaffolds that nucleate processing platforms | Genetic handles for KO studies |
| Inflammasome kinases | Phosphorylate sensors to promote processing | Drug target class |
| Ubiquitin ligases | Control stability of processing components | CRISPR screening hits |
| Protease inhibitors | Endogenous brakes on processing | Counter-screen controls |
| Secretory cargo receptors | Direct mature products to secretion | Secretomics applications |
| Membrane lipid sensors | Recruit platforms to lipid microdomains | Lipid signalling studies |
How Is positive regulation of protein processing Regulated?
Positive regulation of protein processing is controlled at several levels. Upstream, pattern-recognition receptors and cytokine receptors initiate signalling that converges on platform assembly. Post-translational modifications are decisive: phosphorylation of NLRP3 and other sensors promotes processing, while ubiquitination can either stabilize or degrade processing components depending on the ligase. Metabolite-derived modifications add another layer, with histone lactylation and protein succinylation influencing the expression and activity of processing machinery. Lipid signals such as lysophosphatidylcholine can amplify macrophage pyroptosis through GITR-dependent regulation of NLRP3. Finally, acetylation of processing enzymes such as FEN1 provides a reversible switch that can be targeted experimentally.
positive regulation of protein processing and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NLRP3 | Sepsis-associated pyroptosis | LPS-induced macrophage KO model |
| CD274 (PD-L1) | Tumour immune evasion | Tumour cell overexpression and KO |
| OGT | Endometrial malignancy | Endometrial cancer cell line with FBXO31 KO |
| Histone H4 lactylation | Breast cancer epigenetics | Breast cancer organoid with point mutation |
| Succinylated proteins | Allergic airway inflammation | Airway epithelial overexpression model |
Cancer immune evasion and checkpoint biology
Positive regulation of protein processing contributes to the display and function of immune checkpoint proteins. PD-L1 expression in the tumour microenvironment is shaped by post-translational and processing-related events, and its regulation is a major determinant of response to immunotherapy. Metabolic and ubiquitin-dependent pathways, including FBXO31-mediated control of OGT, further link processing homeostasis to endometrial malignancy. These findings position GO:0010954 regulators as candidate biomarkers and combination targets in oncology.
Sepsis and inflammasome-driven inflammation
In sepsis, excessive inflammasome activation drives macrophage pyroptosis and cytokine storm. GITR exacerbates lysophosphatidylcholine-induced macrophage pyroptosis by post-translationally regulating NLRP3, directly implicating positive regulation of protein processing in disease severity. The broader regulatory mechanisms of NLRP3 inflammasome activation are well reviewed and provide a framework for therapeutic intervention.
Allergic airway inflammation and metabolic signalling
Gut flora-derived succinate exacerbates allergic airway inflammation by promoting protein succinylation, demonstrating that metabolite-driven modifications can feed into processing-related pathways. This suggests that dietary and microbiome factors may tune GO:0010954 activity in barrier tissues.
Methodological and cross-species insights
Studies of DNA processing enzyme FEN1 and its regulation by lysine acetylation provide methodological templates for dissecting reversible modifications that control processing enzymes. In plants, BIK1 directly phosphorylates RbohD to control immunity, illustrating that positive regulation of processing-like outputs is evolutionarily conserved.
From positive regulation of protein processing-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for substrate cleavage? | CRISPR knockout in a processing-competent cell line |
| Does a specific phosphorylation site control protease activation? | Point mutation knock-in of the phospho-dead or phospho-mimetic residue |
| Can a processing reporter be tracked in live cells? | Tagged knock-in of a fluorescent cleavage reporter |
| Does overexpression amplify processing output? | Doxycycline-inducible overexpression |
| Which genes are positive regulators in a genome-wide screen? | CRISPR library screening with a processing-dependent selection |
| How does a disease variant alter processing? | Patient-derived knock-in organoids |
How to Study the positive regulation of protein processing Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Western blot | Precursor and mature protein forms | Validation of processing after gene KO |
| Activity-based probe labelling | Active protease pool | Inflammasome activation assays |
| Secretomics | Released cleavage products | Cytokine maturation studies |
| CRISPR knockout screen | Genes required for processing | Genome-wide regulator discovery |
| Phospho-specific antibodies | Activating phosphorylation of sensors | NLRP3 regulation studies |
| Proximity labelling | Platform composition | Membrane processing complexes |
| Live-cell imaging | Spatiotemporal cleavage | Reporter knock-in lines |
| Ubiquitin enrichment | Stability control of processing components | Ligase-substrate mapping |
Proteomics and secretomics
Mass spectrometry-based proteomics can quantify precursor and mature forms of processing substrates, while secretomics captures released cleavage products. These approaches are essential for assigning a gene to GO:0010954 because they measure the mature product directly.
Activity-based probes and enzymatic assays
Fluorogenic or biotinylated activity-based probes label active proteases and allow researchers to distinguish activation from abundance. Such assays are standard in inflammasome and protease biology.
CRISPR screening with processing readouts
Genome-wide CRISPR knockout or activation screens coupled to a processing-dependent reporter or selection can identify positive regulators at scale. Hits are then validated individually with the models described above.
Imaging and proximity labelling
Live-cell imaging of tagged substrates and proximity labelling of processing platforms reveal where and when cleavage occurs. These methods complement biochemical assays and are particularly useful for membrane-associated processing events.
How CRISPR Can Be Used to Study GO:0010954 positive regulation of protein processing
Knockout
CRISPR knockout of candidate positive regulators is the fastest way to test necessity. For example, knocking out NLRP3 or its upstream regulators abolishes processing-dependent readouts in macrophage models. Knockout of FBXO31 stabilizes OGT and alters processing-related homeostasis, demonstrating how KO can reveal pathway directionality.
Point Mutation
Point mutation knock-in allows precise testing of phosphorylation, ubiquitination or acetylation sites. A phospho-dead mutation in a sensor can prevent platform assembly, while a phospho-mimetic can constitutively activate processing. Similar logic applies to acetylation sites in processing enzymes such as FEN1.
Knock-in
Tagged knock-in of processing substrates or proteases enables live tracking and affinity purification. Fluorescent cleavage reporters inserted at endogenous loci provide physiological expression levels and are ideal for screening. Knock-in of disease-associated variants can model patient-specific processing defects.
Overexpression
Inducible overexpression of a candidate regulator tests sufficiency. Overexpressing PD-L1 or its processing regulators can increase checkpoint display and immune evasion in tumour models. Overexpression of succinylation-related enzymes can exacerbate allergic airway inflammation, linking metabolite-driven modification to processing output.
How EDITGENE Supports positive regulation of protein processing Research
Researchers studying positive regulation of protein processing-related genes often need to determine whether a candidate gene is causally involved in precursor cleavage, whether a specific residue controls activation, and whether the effect is sufficient or only permissive. Answering these questions requires precise, isogenic cell models that separate processing from transcription and translation. EDITGENE provides the full toolkit to build such models at scale.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of protein processing research.
Frequently Asked Questions About positive regulation of protein processing
What is GO:0010954 positive regulation of protein processing?
It is a Gene Ontology biological_process term meaning any process that increases the rate, frequency or extent of protein maturation by peptide bond cleavage.
What genes are involved in positive regulation of protein processing?
Key genes include NLRP3, CASP1, GITR, CD274 (PD-L1), OGT, FBXO31, BIK1 and FEN1, among others.
How is positive regulation of protein processing different from protein processing itself?
Protein processing is the cleavage event; positive regulation of protein processing describes the upstream inputs that make cleavage faster or more extensive.
Why is positive regulation of protein processing important in cancer?
It controls immune checkpoint protein display such as PD-L1 and intersects with metabolic and ubiquitin pathways that drive malignancy.
Which diseases are linked to GO:0010954?
Sepsis, allergic airway inflammation, endometrial malignancy, breast cancer and tumour immune evasion have all been linked to processing-related regulation.
What experimental models are used to study positive regulation of protein processing?
CRISPR knockout, point mutation, knock-in, overexpression and CRISPR library screening in isogenic cell lines are standard.
How do you measure positive regulation of protein processing?
Western blot of precursor and mature forms, activity-based probes, secretomics and live-cell cleavage reporters are commonly used.
Can CRISPR screens identify new regulators of protein processing?
Yes, genome-wide CRISPR screens with processing-dependent readouts have identified positive regulators and are a core discovery method.
What is the role of NLRP3 in positive regulation of protein processing?
NLRP3 is a sensor whose post-translational regulation licenses inflammasome assembly and downstream caspase-1-dependent processing.
How does EDITGENE support research on GO:0010954?
EDITGENE provides knockout, point-mutation, knock-in, overexpression cell models and CRISPR library screening with bioinformatics for processing-focused studies.
Conclusion
GO:0010954 positive regulation of protein processing captures a fast, decisive and druggable layer of cellular control. Its molecular logic spans sensor phosphorylation, platform assembly, protease activation and substrate cleavage, with well-characterized nodes such as NLRP3, caspase-1, GITR, PD-L1, OGT and FBXO31. Because these events are post-translational, they cannot be inferred from transcriptomics alone; they require functional models that measure mature products directly. CRISPR-based knockout, point-mutation, knock-in and overexpression systems, combined with screening and proteomics, provide the causal evidence needed to move from correlation to mechanism. As the field maps more positive regulators, GO:0010954 will remain a central framework for understanding inflammation, cancer and metabolic disease.
References
- 1. Yi M et al.. 2021. Regulation of PD-L1 expression in the tumor microenvironment.. J Hematol Oncol 14(1):10 PMID: 33413496
- 2. Liang S et al.. 2024. GITR exacerbates lysophosphatidylcholine-induced macrophage pyroptosis in sepsis via posttranslational regulation of NLRP3.. Cell Mol Immunol 21(7):674-688 PMID: 38740925
- 3. Paik S et al.. 2021. An update on the regulatory mechanisms of NLRP3 inflammasome activation.. Cell Mol Immunol 18(5):1141-1160 PMID: 33850310
- 4. Zhang N et al.. 2025. FBXO31-mediated ubiquitination of OGT maintains O-GlcNAcylation homeostasis to restrain endometrial malignancy.. Nat Commun 16(1):1274 PMID: 39894887
- 5. Liu J et al.. 2025. H4K79 and H4K91 histone lactylation, newly identified lactylation sites enriched in breast cancer.. J Exp Clin Cancer Res 44(1):252 PMID: 40849487
- 6. Wang C et al.. 2025. Gut flora-derived succinate exacerbates Allergic Airway Inflammation by promoting protein succinylation.. Redox Biol 82:103623 PMID: 40174477
- 7. Ononye OE et al.. 2019. Analysis of DNA Processing Enzyme FEN1 and Its Regulation by Protein Lysine Acetylation.. Methods Mol Biol 1983:207-224 PMID: 31087300
- 8. Li L et al.. 2014. The FLS2-associated kinase BIK1 directly phosphorylates the NADPH oxidase RbohD to control plant immunity.. Cell Host Microbe 15(3):329-38 PMID: 24629339
